Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 15

Acne Comorbidities

Authors Wang Y , Zhu M, Wu S, Zheng H

Received 4 October 2022

Accepted for publication 2 November 2022

Published 10 November 2022 Volume 2022:15 Pages 2415—2420

DOI https://doi.org/10.2147/CCID.S392165

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Jeffrey Weinberg



Yun Wang, Mingfang Zhu, Shuhui Wu, Huie Zheng

Department of Dermatology, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, People’s Republic of China

Correspondence: Mingfang Zhu, Department of Dermatology, The Second Affiliated Hospital of Hunan University of Chinese Medicine, 233 Cai E North Road, Kaifu District, Changsha, People’s Republic of China, Tel +86-13907317358, Fax +86-731-84917727, Email [email protected]

Abstract: Acne vulgaris is a multifactorial chronic inflammatory disorder of the pilosebaceous unit, and it represents the most common skin disease affecting about 85% of adolescents in Western populations. The prevalence of acne vulgaris in developed countries is higher than that in developing countries.Emerging data has shown some systemic diseases closely associated with acne, including obesity, diabetes mellitus, cardiovascular diseases, metabolic syndrome (Mets), and so on.This review summarizes acne-associated diseases that have been reported in studies, and analyzes the possible co-pathogenesis of these diseases and acne.

Keywords: acne, comorbidity, metabolic diseases, diabetes mellitus, obesity

Introduction

Acne vulgaris is a chronic inflammatory skin disease involving the sebaceous glands of the hair follicles. Epidemiological and basic scientific studies have made us gradually realize that acne is not only a skin disease, but also an important systemic disease, which can occur successively or concurrently with a variety of systemic and metabolic diseases.One study showed that patients with acne have significantly higher total cholesterol (TC) and triglyceride (TG) levels, while their high-density lipoprotein cholesterol (HDL-C) levels were significantly lower.1 Cerman et al2 observed that the glycemic index of acne patients was significantly increased, the serum adiponectin level was significantly decreased, and the glycemic index and serum adiponectin were closely related to diabetes.Our team previously conducted an epidemiological survey on the correlation between acne and glucolipid metabolism diseases, and found that people who had acne before had a higher risk of abnormal glucolipid metabolism than people who did not have acne. Acne is a risk factor for abnormal glucose and lipid metabolism.3 Recently, it has been reported that acne is a multi-gene and multi-target disease,4 which may affect hyperlipidemia, diabetes, and cardiovascular disease through some genes or targets. For example, the latest report found that RETN-420 and IL6-572 gene polymorphisms are closely related to acne susceptibility, and RETN-420G and IL6-572C alleles increase the risk of acne.5 These two gene polymorphisms can lead to the occurrence of metabolic diseases such as obesity, type 2 diabetes, cardiovascular disease, and cancer.6–8 The occurrence of acne is not only regulated by genes, but also by signaling pathways such as insulin-like growth factor 1 (IGF-1) and the mechanistic target of rapamycin complex 1 (mTORC1). Some believe that IGF-1 signaling may be the main pathway in the pathogenesis of acne, which can alleviate acne by inhibiting the proliferation of sebaceous glands and the secretion of sebum,9,10 while others believe that acne vulgaris is a civilized disease driven by mTORC1 signaling. mTORC1 promotes lipid synthesis by activating the transcription factor sterol regulatory element-binding protein 1 (SREBP1), which leads to acne.11 These signaling pathways are also actively involved in the occurrence and development of metabolic diseases.12 In addition to the above commonalities, acne shares common dietary habits with these metabolic diseases, ie high sugar, high carbohydrate, and high dairy.13 Through experimental studies, our team found that milk can promote sebum secretion in golden hamsters through the IGF-1/SREBP/ACC-1 signaling pathway,14 and the increase of sebum secretion is one of the pathogenesis of acne.Some scholars find that having milk and a high-sugar diet can increase the levels of insulin and IGF-1, which in turn over-activates mTORC1 signaling, leading to acne, insulin resistance and increased BMI in adolescents; and early intervention can reduce the incidence of obesity, type 2 diabetes, cancer and other diseases in adults.15 It suggests the possibility of comorbidity between acne and the above-mentioned diseases on the timeline.Other scholars agree with this view,16 arguing that dermatologists should be aware of the potential relationship between acne and insulin resistance and should consider referring acne patients to primary care for further evaluation. Early treatment of insulin resistance can prevent the development of diabetes and cardiovascular disease.Therefore, a thorough understanding of the relationship between acne and metabolic diseases is conducive to the early prevention, screening and treatment of metabolic diseases. This article will respectively discuss the possible common mechanisms of acne and metabolic diseases.

The Relationship Between Acne and Various Metabolic Diseases

The Obesity

major public health problem worldwide, and its prevalence has increased dramatically over the past 20 years. Despite the ambiguity in the use of body mass index (BMI) as a biomarker of current abnormalities and future risk, it is undeniable that obesity has been proven to contribute to cardiovascular and cerebrovascular disease, diabetes, and hypertension.17 Currently, obesity has been found in some studies to increase the risk of acne, and high BMI is a risk factor for acne severity in adolescents.An epidemiological survey found overweight and obese individuals have a significantly higher prevalence in acne vulgaris than healthy individuals, and there is a positive correlation between BMI and acne severity.18 How does obesity lead to acne? The mechanism may be related to the metabolic effect of obesity. Androgen, insulin and insulin growth factor are often increased in obese patients, which can induce the proliferation and differentiation of sebaceous cells through the expression of adipogenic genes, thereby increasing sebum secretion and affecting the severity of acne.19,20 Other studies have shown that the number and percentage of T helper (Th) 17 cells in adipose tissue are increased in obese subjects compared with non-obese subjects, and Th17 cell signaling pathway is a key pathway.21 Obesity impairs the innate immune function of white adipose tissue, and a specific diet (such as high-fat feeding) leads to the secretion of transforming growth factor-β (TGFβ) from over-accumulated mature adipocytes,22 which plays a key role in the differentiation of Th17 cells.23 Our team found that Th17 cells are closely related to the occurrence and development of acne by reviewing the literature.24 In addition, acne and metabolic diseases also share common targets at gene loci. Tumor necrosis factor (TNF)-α rs1800629 (308 G/A) is associated with obesity and metabolic disorders in children, and this SNP has been shown to increase the susceptibility to acne.4,25

The Dyslipidemia

Among patients with acne, there is evidence of an abnormal lipid profile.26,27 Shrestha et al studied 100 women with acne between 2015 and 2016 and found that 15.4% of them had changes in their lipid profiles.28 Since androgens have clear roles in acne pathogenesis, and androgens are derived from plasma cholesterol, lipid alterations might cause acne.29 In studies, plasma TC, TG and low-density lipoprotein cholesterol (LDL) were found to be elevated in patients with acne, and high TC was the most common derangement, particularly in men.30 Common lipid components (TC, TG, LDL) in patients with adult or prepubertal acne flare-ups or severe, persistent acne all accompanied by hirsulosis exceed normal reference ranges. These reports call attention to the fact that changes in lipid levels are present in patients with acne and that dyslipidemia is positively correlated with the onset of acne. Therefore, correct and early intervention may be an important measure to prevent diseases caused by dyslipidemia.

Diabetes

Insulin resistance is a common feature of obesity and type 2 diabetes, but novel approaches of diabetes subtyping (clustering) revealed variable degrees of insulin resistance in people with diabetes.31 Insulin resistance is considered to be an important factor in the pathogenesis of acne, and both insulin and IGF-1 levels are increased in patients with acne.32 Insulin and IGF-1 can promote the synthesis of androgens in the adrenal gland and gonad, thus leading to acne susceptibility.33,34 They can also increase the expression of SREBP-1 through mTORC1 pathway to induce lipid synthesis. However, IGF-1 has a stronger stimulating effect on the production and development of acne sebum than insulin.20,34 Cytokines such as TNF-α, interferon-γ (IFN-γ), interleukin (IL)-6, IL-1β and IL-17 can not only inhibit insulin signal transduction, thereby inhibiting glucose and lipid metabolism, resulting in insulin resistance, but also mediate the inflammatory response of acne.35,36 Given that acne patients are more likely to develop insulin resistance, which may be a pre-stage of type 2 diabetes, close observation is important for controlling disease progression to type 2 diabetes.16

Hypertension

The effect of androgen on blood pressure is well established.37,38 Related experimental results indicate that androgen can be mediated through regulate blood vessel tone of hypertension. For example, testosterone and its precursor androstenedione can increase the expression of thromboxane A2 receptors through androgen receptors’dependency mechanism39 or testosterone can accelerate vascular remodeling by promoting the role of rat vascular smooth muscle cell mitosis, thus promoting the development of hypertension.40 At the same time, excessive androgen secretion is also one of the main mechanisms of acne.According to statistics, male acne patients after puberty are more likely to have higher blood pressure, which may be related to the persistently-high androgen levels after puberty.41 Studies have shown that serum IL-6 levels are positively correlated with blood pressure in hypertensive patients.42,43 TNF-α is one of the important inflammatory indicators of hypertensive plaques, which can inhibit autophagy and aggravate the formation of hypertensive plaques by inducing p38MAPK phosphorylation.44,45 Reducing serum IL-1β and nuclear factor kappa B (NF-κB) levels can improve hypothalamic leptin resistance, thereby inhibiting central sympathetic nerve excitation-mediated increase in blood pressure.46,47 The above cytokines also mediate the inflammatory response of acne.

Cardiovascular Diseases

There is no report on the direct association between acne and atherosclerosis, or coronary vascular disease, but risk factors affecting cardiovascular disease, such as obesity, hyperlipidemia, hypertension, diabetes, etc., are significantly related to acne. McCullough et al48 reported that androgens can significantly reduce high-density lipoprotein and increase low-density lipoprotein, and the increase of low-density lipoprotein levels can promote the formation of atherosclerosis.The apolipoprotein B/apolipoprotein A1 (ApoB/ApoA1) ratio is an important indicator for preventing the occurrence and development of cardiovascular disease.49,50 If it increases, the risk of cardiovascular disease increases.Androgens that lead to acneigenesis can also lead to elevated ApoB/ApoA1.51 Studies have found that IL-17, TNF-α, Toll-like receptors, and NF-κB pathways are actively involved in the occurrence and development of cardiovascular diseases,52–55 and these targets and pathways are also involved in the occurrence and development of acne. Acne and cardiovascular disease may have common targets and pathways.

Metabolic Syndrome

MetS includes abdominal obesity, low-grade chronic systemic inflammation, altered glucose metabolism, dyslipidemia, and hypertension. Dietary habits, sedentary, less physical activity, and oxidative stress can contribute to the development of the disease. It is the current global epidemic and major public health care problem. Recently, several authors have highlighted the link between this syndrome and acne, which they suggest increases the odds of developing metabolic syndrome.56,57 mTORC1 signaling pathway is the common feature between them.The expression of mTORC1 is increased in the skin lesions of acne patients,58,59 and the attenuation of mTORC1 signaling can achieve the effect of acne treatment.60–62 This signaling pathway is a central regulator of cell growth and anabolism, and plays an important role in various metabolic diseases such as obesity, insulin resistance, and type 2 diabetes.11

Other Diseases

Acne has been reported to be associated with increased sinus infections, asthma, non-asthmatic lung disease, reflux, abdominal pain, nausea and food allergies, depression, anxiety, attention deficit hyperactivity disorder, and insomnia.11,63,64

The Etiological Link Between Acne and Metabolic Diseases

Factors such as common dietary structure, genetic susceptibility, immune-inflammatory pathways, and the influence of high androgen levels may be the reasons for the increased incidence of acne comorbidity.On the one hand, patients with acne have a higher incidence of comorbidities. For example, patients with acne are prone to symptoms such as anxiety and insomnia, which in turn affect obesity, cardiovascular disease, etc.; Patients such as diabetes, obesity, etc., have a higher probability of acne than normal people, and acne, obesity, diabetes and other diseases are regulated by the same gene locus RETN-420.5,6 It is well known that insulin resistance, obesity, and type 2 diabetes can develop through a kinase pathway known as the target of mammalian mTORC1,65,66 which is also one of the important mechanisms of acne pathogenesis.67 On the other hand, comorbidities can interact with each other, such as obesity, hyperlipidemia, hypertension, and diabetes, which are all high-risk factors for cardiovascular disease.

Conclusions

Acne is a disease caused by multiple factors and abnormal expression of multiple genes. Although in-depth studies have been conducted on various factors including skin microecological changes, androgen induction, keratinization of pilosebaceous ducts, the release of pro-inflammatory factors, environmental pollution, sunlight, ultraviolet rays, dietary changes, etc., the pathogenesis of acne is yet to be thoroughly understood. It is a common understanding that endogenous factors are closely related to acne. In 2020, a prospective case-control study of serum FoxO1, mTORC1, IGF-1, IGFBP-3 levels and metabolic syndrome in patients with acne vulgaris in Turkey suggested that acne was associated with hypertension, insulin-like growth factor-binding protein-3 (IGFBP-3), HDL and factors related to Mets, the concept of acne comorbidity was proposed for the first time, and new treatment strategies were suggested.32 The latest data indicate that the pathogenesis of acne shares features of other metabolic diseases in which TREM2 macrophages and lipid dysregulation are prominent.68 Acne and the above diseases have many common pathogenesis mechanisms, and there is the possibility of comorbidity. The form of their comorbidity may be concurrent existence, sequential existence, or mutually-causal existence. They may be in the same spectrum of metabolic diseases, and under the regulation of gene polymorphisms, they manifest as different diseases at different ages.From the perspective of the “Butterfly Effect”, attention should be paid to the “whistleblower” function of acne to other diseases, and reduce the over-activation of MTORC1 signal, which can warn and intervene the occurrence of metabolic diseases in advance, so as to prevent more serious diseases.Dermatologists can make lifestyle changes to acne sufferers at an early age to prevent or delay the onset of the disease.

Abbreviations

Mets, metabolic syndrome; TC, higher total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; IGF-1, insulin-like growth factor 1; mTORC1, mechanistic target of rapamycin complex 1; SREBP1, sterol regulatory element-binding protein 1; BMI, body mass index; Th17, T helper 17 cells; TGFβ, transforming growth factor-β; TNF, Tumor necrosis factor; LDL, low-density lipoprotein cholesterol; IFN-γ, interferon-γ; IL, interleukin; NF-κB, nuclear factor kappa B; ApoB/ApoA1, apolipoprotein B/apolipoprotein A1.

Funding

This work was funded by the National Natural Science Foundation of China (82174375), the Hunan Province High-Level Health Talents 225 Project (Xiangweihan [2019]196), Hunan Province Clinical Medical Technology Innovation Guidance Project (2020SK51301), Scientific Research Project of Hunan Provincial Health Commission (202202124772), and Traditional Chinese Medicine Scientific Reseaech Project of Hunan Province (C2022026), Leading TCM talents in Hunan Province.

Disclosure

The authors report no conflicts of interest in this work.

References

1. Younis S, Shamim S, Nisar K, et al. Association of TNF-alpha polymorphisms (−857, −863 and −1031), TNF-alpha serum level and lipid profile with acne vulgaris. Saudi J Biol Sci. 2021;28(11):6615–6620. doi:10.1016/j.sjbs.2021.07.042

2. Cerman AA, Aktas E, Altunay IK, et al. Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris. J Am Acad Dermatol. 2016;75(1):155–162. doi:10.1016/j.jaad.2016.02.1220

3. Zhou J. Association between acne and abnormal glucose and lipid metabolism. Hunan Univ Tradit Chin Med. 2021;26:45.

4. Elsaie ML, Aly DG. The immunogenetics of acne. Adv Exp Med Biol. 2022;1367:137–154.

5. Chen X, Min S, Chen C, et al. Influence of RETN, IL-1, and IL-6 gene polymorphisms on the risk of acne vulgaris in the Chinese population. J Cosmet Dermatol. 2022. doi:10.1111/jocd.14911

6. Rathwa N, Patel R, Palit SP, et al. Genetic variants of resistin and its plasma levels: association with obesity and dyslipidemia related to type 2 diabetes susceptibility. Genomics. 2019;111(4):980–985. doi:10.1016/j.ygeno.2018.06.005

7. Li H. Association Interleukin-6 Gene Polymorphisms with Type 2 Diabetic Retinopathy in Dali Bai Population. Dali University; 2016.

8. Harun-Or-Roshid M, Ali MB, Mollah M, et al. Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk. PLoS One. 2021;16(3):e247055. doi:10.1371/journal.pone.0247055

9. Akpinar KY. Evaluation of serum insulin-like growth factor-1, insulin, glucose levels in patients with adolescent and post-adolescent acne. J Cosmet Dermatol. 2022;21(3):1292–1296. doi:10.1111/jocd.14327

10. Zhu Y, Peng Z, Lu C. To explore the mechanism of pomegranate peel polyphenol cream on acne sebum metabolism based on IGF-1. Hunan Univ Tradit Chin Med. 2020;15. doi:10.1186/s13020-020-00325-x

11. Melnik BC. Acne vulgaris: the metabolic syndrome of the pilosebaceous follicle. Clin Dermatol. 2018;36(1):29–40. doi:10.1016/j.clindermatol.2017.09.006

12. Janssen J. Hyperinsulinemia and its pivotal role in aging, obesity, type 2 diabetes, cardiovascular disease and cancer. Int J Mol Sci. 2021;22(15):7797. doi:10.3390/ijms22157797

13. Clatici VG, Voicu C, Voaides C, et al. Diseases of civilization - cancer, diabetes, obesity and acne - the implication of milk, IGF-1 and mTORC1. Maedica. 2018;13(4):273–281. doi:10.26574/maedica.2018.13.4.273

14. Shuhui W, Mingfang Z, Xi Z, et al. Effect of milk on sebaceous gland spots and IGF-1/SREBP-1/ACC-1 signaling pathway in golden hamsters. Chin J Dermatol. 2022;55(03):238–242.

15. Melnik BC, John SM, Plewig G. Acne: risk indicator for increased body mass index and insulin resistance. Acta Derm Venereol. 2013;93(6):644–649. doi:10.2340/00015555-1677

16. Nickles MA, Sharma D, Tsoukas MM, et al. Acne and insulin resistance: a systematic review and meta-analysis. J Am Acad Dermatol. 2022;87(3):687–688. doi:10.1016/j.jaad.2021.12.033

17. Alan S, Cenesizoglu E. Effects of hyperandrogenism and high body mass index on acne severity in women. Saudi Med J. 2014;35(8):886–889.

18. Alshammrie FF, Alshammari R, Alharbi RM, et al. Epidemiology of acne vulgaris and its association with lifestyle among adolescents and young adults in Hail, Kingdom of Saudi Arabia: a Community-Based Study. Cureus. 2020;12(7):e9277. doi:10.7759/cureus.9277

19. Hirt PA, Castillo DE, Yosipovitch G, et al. Skin changes in the obese patient. J Am Acad Dermatol. 2019;81(5):1037–1057. doi:10.1016/j.jaad.2018.12.070

20. Cong TX, Hao D, Wen X, et al. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res. 2019;311(5):337–349. doi:10.1007/s00403-019-01908-x

21. Cheng Z, Xiong X, Wu F, et al. Network pharmacology research indicates that Wu-Mei-Wan treats obesity by inhibiting Th17 cell differentiation and alleviating metabolic inflammation. Comb Chem High Throughput Screen. 2022;25. doi:10.2174/1386207325666220221121919

22. Zhang LJ, Guerrero-Juarez CF, Chen SX, et al. Diet-induced obesity promotes infection by impairment of the innate antimicrobial defense function of dermal adipocyte progenitors. Sci Transl Med. 2021;13(577):eabb5280. doi:10.1126/scitranslmed.abb5280

23. Chang D, Xing Q, Su Y, et al. The conserved non-coding sequences CNS6 and CNS9 control cytokine-induced rorc transcription during T helper 17 cell differentiation. Immunity. 2020;53(3):614–626. doi:10.1016/j.immuni.2020.07.012

24. Lu WEI, Zhang J-G, Ming-fang Z. Research progress of Th17 in the pathogenesis of acne. J Clin Dermatol. 2021;50(02):122–124.

25. Guixian W, Wenming Z, Zhenjun S. Association of single nucleotide polymorphism of TNF-α gene G308A with obesity and metabolic disorder in children. Chin J Endocrinol Metab. 2021;37(10):924–929.

26. Abulnaja KO. Changes in the hormone and lipid profile of obese adolescent Saudi females with acne vulgaris. Braz J Med Biol Res. 2009;42(6):501–505. doi:10.1590/S0100-879X2009000600005

27. Bakry OA, El SR, El FS, et al. Role of hormones and blood lipids in the pathogenesis of acne vulgaris in non-obese, non-hirsute females. Indian Dermatol Online J. 2014;5(Suppl 1):S9–S16. doi:10.4103/2229-5178.144506

28. Shrestha S. Correlation of hormonal profile and lipid levels with female adult acne in a tertiary care center of Nepal. J Nepal Health Res Counc. 2018;16(2):222–227. doi:10.33314/jnhrc.v16i2.1178

29. Da CM, Batista AL, Macedo MS, et al. Study of lipid profile in adult women with acne. Clin Cosmet Investig Dermatol. 2015;8:449–454. doi:10.2147/CCID.S83248

30. Sobhan M, Seif RM, Amerifar M. Correlation between lipid profile and acne vulgaris. Clin Cosmet Investig Dermatol. 2020;13:67–71. doi:10.2147/CCID.S230617

31. Mastrototaro L, Roden M. Insulin resistance and insulin sensitizing agents. Metabolism. 2021;125:154892. doi:10.1016/j.metabol.2021.154892

32. Aktas KE, Saltik ZA, Unay DO. Evaluation of serum FoxO1, mTORC1, IGF-1, IGFBP-3 levels, and metabolic syndrome components in patients with acne vulgaris: a prospective case-control study. Dermatol Ther. 2020;33(6):e13887. doi:10.1111/dth.13887

33. Unluhizarci K, Karaca Z, Kelestimur F. Role of insulin and insulin resistance in androgen excess disorders. World J Diabetes. 2021;12(5):616–629. doi:10.4239/wjd.v12.i5.616

34. Zinati-Saeed S, Shakiba E, Rahimi Z, et al. The insulin-like growth factor-1 (G>A) and 5,10-methylenetetrahydrofolate reductase (C677T) gene variants and the serum levels of insulin-like growth factor-1, insulin, and homeostasis model assessment in patients with acne vulgaris. Iran J Pathol. 2020;15(1):23–29. doi:10.30699/ijp.2019.105695.2098

35. Yiqiu W, Man L, Jia Y. Research progress in the relationship between chronic inflammation and insulin resistance. J Clin Pathol Res. 2019;39(03):640–645.

36. Jieya Y, Wenzhong X, Xiuzu S. Metabolic syndrome and skin diseases. Chin J Dermatol. 2021;54(07):642–645.

37. Colafella K, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14(3):185–201. doi:10.1038/nrneph.2017.189

38. Ziemens B, Wallaschofski H, Volzke H, et al. Positive association between testosterone, blood pressure, and hypertension in women: longitudinal findings from the Study of Health in Pomerania. J Hypertens. 2013;31(6):1106–1113. doi:10.1097/HJH.0b013e3283603eb1

39. Matsuda K, Ruff A, Morinelli TA, et al. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol. 1994;267(3 Pt 2):H887–H893. doi:10.1152/ajpheart.1994.267.3.H887

40. McCrohon JA, Jessup W, Handelsman DJ, et al. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation. 1999;99(17):2317–2322. doi:10.1161/01.CIR.99.17.2317

41. Nagpal M, De D, Handa S, et al. Insulin resistance and metabolic syndrome in young men with acne. JAMA Dermatol. 2016;152(4):399–404. doi:10.1001/jamadermatol.2015.4499

42. Serrano NC, Guio E, Becerra-Bayona SM, et al. C-reactive protein, interleukin-6 and pre-eclampsia: large-scale evidence from the GenPE case-control study. Scand J Clin Lab Invest. 2020;80(5):381–387. doi:10.1080/00365513.2020.1747110

43. Morawiec E, Cholewa K, Zenderowski M, et al. The expression profile of genes encoding tumor necrosis factor-alpha, interleukin-6 and their receptor in benign adrenal tumors. J Physiol Pharmacol. 2020;71(4). doi:10.26402/jpp.2020.4.11

44. Gao H, Bigalke J, Jiang E, et al. TNFalpha triggers an augmented inflammatory response in brain neurons from dahl salt-sensitive rats compared with normal sprague dawley rats. Cell Mol Neurobiol. 2022;42(6):1787–1800. doi:10.1007/s10571-021-01056-9

45. Shaohong S, Lin Z, Junfeng Z. Total glucosides of paeony has effect on TNF-α/P38MAPK/NF-κB/RBP4 signaling pathways in rats with atherosclerosis and its regulating effect on IL-17, IL-27 and IL-33 in serum. New Chin Med. 2019;51(07):18–21.

46. Na L, Yan Z, Ying J. Correlation between NF – κB /RBP4 signaling pathway and changes of inflammatory factors in patients with hypertension. J Clin Exp Med. 2021;20(24):2592–2595.

47. Du-fang M, Lu C, Ping J, et al. Activation of α7 nAChR attenuates diet-induced obesity-associated hypertension in rats by suppressing chronic inflammation. Chin J Pathophysiol. 2021;37(12):2131–2138.

48. McCullough D, Webb R, Enright KJ, et al. How the love of muscle can break a heart: impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health. Rev Endocr Metab Disord. 2021;22(2):389–405. doi:10.1007/s11154-020-09616-y

49. Reynoso-Villalpando GL, Sevillano-Collantes C, Valle Y, et al. ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women. Endocrinol Diabetes Nutr. 2019;66(8):502–511. doi:10.1016/j.endinu.2019.03.019

50. Bodde MC, Hermans M, Jukema JW, et al. Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up. Clin Res Cardiol. 2019;108(5):520–538.

51. Qian-qian Y, Yi-juan C, Xiao-nan Y, et al. Effect of obesity and high free androgen index on the increase of apolipoprotein B/A1 ratio in PCOS patients of different ages. J Reprod Med. 2021;30(09):1212–1216.

52. Liao YH, Xia N, Zhou SF, et al. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol. 2012;59(4):420–429. doi:10.1016/j.jacc.2011.10.863

53. Xing Y, Deng W, Tang Q. Role of toll-like receptor in cardiovascular diseases. Adv Cardiovascu Dis. 2021;42(08):711–715.

54. Ding G, Cheng L, Qin Q, et al. PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes. J Mol Cell Cardiol. 2006;40(6):821–828. doi:10.1016/j.yjmcc.2006.03.422

55. Han M. Role of Targeted Inhibition of NF-Κbsignaling Pathway in Myocardial Ischemia-Reperfusion Injury in Aged Mice. Xinjiang Medical University; 2020.

56. Biagi LG, Sanudo A, Bagatin E. Severe acne and metabolic syndrome: a possible correlation. Dermatology. 2019;235(6):456–462. doi:10.1159/000501986

57. Yu-xi A, Lin C. Acne vulgaris and metabolic syndrome. J Pract Dermatol. 2020;13(06):359–362.

58. Inoue T, Miki Y, Kakuo S, et al. Expression of steroidogenic enzymes in human sebaceous glands. J Endocrinol. 2014;222(3):301–312. doi:10.1530/JOE-14-0323

59. Monfrecola G, Lembo S, Caiazzo G, et al. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients’ skin. Exp Dermatol. 2016;25(2):153–155. doi:10.1111/exd.12885

60. Melnik BC. Acne vulgaris: an inflammasomopathy of the sebaceous follicle induced by deviated FoxO1/mTORC1 signalling. Br J Dermatol. 2016;174(6):1186–1188. doi:10.1111/bjd.14564

61. Howell JJ, Hellberg K, Turner M, et al. Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex. Cell Metab. 2017;25(2):463–471. doi:10.1016/j.cmet.2016.12.009

62. Robinson S, Kwan Z, Tang MM. Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris: a randomized open-labeled study. Dermatol Ther. 2019;32(4):e12953. doi:10.1111/dth.12953

63. Silverberg JI, Silverberg NB. Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a U.S. population-based study. Br J Dermatol. 2014;170(5):1136–1142. doi:10.1111/bjd.12912

64. Misery L, Wolkenstein P, Amici JM, et al. Consequences of acne on stress, fatigue, sleep disorders and sexual activity: a population-based study. Acta Derm Venereol. 2015;95(4):485–488. doi:10.2340/00015555-1998

65. Bar-Tana J. Type 2 diabetes - unmet need, unresolved pathogenesis, mTORC1-centric paradigm. Rev Endocr Metab Disord. 2020;21(4):613–629. doi:10.1007/s11154-020-09545-w

66. Akhaphong B, Baumann DC, Beetch M, et al. Placental mTOR complex 1 regulates fetal programming of obesity and insulin resistance in mice. JCI Insight. 2021;6(13):e149271. doi:10.1172/jci.insight.149271

67. Melnik BC. Lifetime impact of cow’s milk on overactivation of mTORC1: from fetal to childhood overgrowth, acne, diabetes, cancers, and neurodegeneration. Biomolecules. 2021;11(3):404. doi:10.3390/biom11030404

68. Do TH, Ma F, Andrade PR, et al. TREM2 macrophages induced by human lipids drive inflammation in acne lesions. Sci Immunol. 2022;7(73):o2787. doi:10.1126/sciimmunol.abo2787

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.